Collaborations

Boehringer Ingelheim is involved in long-term collaborations with world leading academics, industry, regulators and payors, as well as patients and advocacy organizations.
We take a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful areas of cancer research.